Stay informed with the latest litigation news. Explore now

Dry Power Inhaler Devices And Dry Power Formulations For Enhancing Dosing Efficiency - EP1617820B1

EP1617820

VECTURA
Application Number
EP04727320A
Filing Date
Apr 14, 2004
Status
Revoked
Feb 26, 2021
Grant Date
Mar 21, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Bibliography

The patent EP1617820B1 was granted to Vectura on Mar 21, 2018 following the initial filing on Apr 14, 2004 under the application number EP04727320A . The current legal status of the patent is Revoked.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

TEVA PHARMACEUTICALSDec 21, 2018ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents